Allergy & Respiratory
Operational excellence in Allergy & Respiratory trials
Your goal is to differentiate and deliver the best respiratory treatment in a competitive arena. We can help.
Your goal is to differentiate and deliver the best respiratory treatment in a competitive arena. We can help.
When you combine our domain expertise with our therapeutic expertise, the result is a partner with extensive experience in addressing the challenges faced in this complex and highly competitive space. The expert combination of therapeutic strategy, medical strategy, and program management result in an established, effective approach.
We have broad expertise ranging from chronic inflammatory airway disorders such as Asthma and COPD to allergic disorders including Allergic Rhinitis and Food Allergies. Here are some of the other areas we’ve studied:
See How AI and RWD Accelerate Respiratory Insights
IQVIA Decentralized Trials deliver purpose-built clinical services and industry-leading technologies that engage the right patients wherever they are.
Build on our experience of more than 245 rare disease studies in 96 countries to fulfill your promise of hope to millions around the world.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.